Ouyang M - Search Results

1

Coagulation dysfunction events associated with echinocandins: a real-world study from FDA adverse event reporting system (FAERS) database.

Cheng Q, Wu Y, Yao Z, Ouyang M, Zou S, Shi X, Zhao Y, Sun M. Cheng Q, et al. Among authors: ouyang m. Thromb J. 2024 Aug 23;22(1):78. doi: 10.1186/s12959-024-00641-4. Thromb J. 2024. PMID: 39180077 Free PMC article.

2

Post-marketing safety of anti-IL-5 monoclonal antibodies (mAbs): an analysis of the FDA Adverse Event Reporting System (FAERS).

Zou SP, Yang HY, Ouyang M, Cheng Q, Shi X, Sun MH. Zou SP, et al. Among authors: ouyang m. Expert Opin Drug Saf. 2024 Mar;23(3):353-362. doi: 10.1080/14740338.2023.2251382. Epub 2023 Aug 29. Expert Opin Drug Saf. 2024. PMID: 37610085

3

A disproportionality analysis of adverse events associated to pertuzumab in the FDA Adverse Event Reporting System (FAERS).

Zou SP, Yang HY, Ouyang ML, Cheng Q, Shi X, Sun MH. Zou SP, et al. BMC Pharmacol Toxicol. 2023 Nov 13;24(1):62. doi: 10.1186/s40360-023-00702-w. BMC Pharmacol Toxicol. 2023. PMID: 37957717 Free PMC article.

4

Acid-suppressive drugs: A systematic review and network meta-analysis of their nocturnal acid-inhibitory effect.

Zou S, Ouyang M, Cheng Q, Shi X, Sun M. Zou S, et al. Among authors: ouyang m. Pharmacotherapy. 2024 Feb;44(2):171-183. doi: 10.1002/phar.2899. Epub 2023 Dec 12. Pharmacotherapy. 2024. PMID: 38049205

5

Effect of potassium-competitive acid blockers on human gut microbiota: a systematic review and meta-analysis.

Ouyang ML, Zou SP, Cheng Q, Shi X, Zhao YZ, Sun MH. Ouyang ML, et al. Front Pharmacol. 2023 Dec 13;14:1269125. doi: 10.3389/fphar.2023.1269125. eCollection 2023. Front Pharmacol. 2023. PMID: 38192408 Free PMC article.

6

Comparative Efficacy and Safety of Potassium-Competitive Acid Blockers vs. Proton Pump Inhibitors for Peptic Ulcer with or without Helicobacter pylori Infection: A Systematic Review and Network Meta-Analysis.

Ouyang M, Zou S, Cheng Q, Shi X, Zhao Y, Sun M. Ouyang M, et al. Pharmaceuticals (Basel). 2024 May 28;17(6):698. doi: 10.3390/ph17060698. Pharmaceuticals (Basel). 2024. PMID: 38931366 Free PMC article. Review.

7

A disproportionality analysis of adverse events caused by GnRHas from the FAERS and JADER databases.

Zou S, Ouyang M, Zhao Y, Cheng Q, Shi X, Sun M. Zou S, et al. Among authors: ouyang m. Front Pharmacol. 2024 Jul 4;15:1392914. doi: 10.3389/fphar.2024.1392914. eCollection 2024. Front Pharmacol. 2024. PMID: 39027335 Free PMC article.

8

Vonoprazan-associated Clostridioides difficile infection: an analysis of the Japanese Adverse Drug Event Report and the FDA Adverse Event Reporting System.

Ouyang M, Zou S, Cheng Q, Shi X, Zhao Y, Sun M. Ouyang M, et al. Ther Adv Drug Saf. 2024 Jul 31;15:20420986241260211. doi: 10.1177/20420986241260211. eCollection 2024. Ther Adv Drug Saf. 2024. PMID: 39091466 Free PMC article.

9

Comparative Efficacy and Safety of Potassium-Competitive Acid Blockers and Proton Pump Inhibitors for First-Line Helicobacter pylori Eradication Therapy: A Systematic Review and Network Meta-Analysis.

Ouyang M, Zou S, Cheng Q, Shi X, Sun M. Ouyang M, et al. Helicobacter. 2024 Nov-Dec;29(6):e13150. doi: 10.1111/hel.13150. Helicobacter. 2024. PMID: 39508303

10

Pulmonary toxicity assessment of tumor necrosis factor α inhibitors in the treatment of IBD: a real world study based on US food and drug administration adverse events reporting system (FAERS).

Sun S, Shi X, Ouyang M, Zou S, Zhao Y, Cheng Q. Sun S, et al. Among authors: ouyang m. Expert Opin Drug Saf. 2024 Dec 20:1-8. doi: 10.1080/14740338.2024.2444580. Online ahead of print. Expert Opin Drug Saf. 2024. PMID: 39695351

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

881 results

Search Page

Filters